Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036620 | SCV000060275 | likely benign | not specified | 2015-10-27 | criteria provided, single submitter | clinical testing | p.Asn269Asn in exon 15 of TNNT2: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 6/29960 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs376923877). |
Eurofins Ntd Llc |
RCV000724379 | SCV000226234 | uncertain significance | not provided | 2015-01-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000036620 | SCV000533746 | likely benign | not specified | 2017-06-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000777961 | SCV000914062 | likely benign | Cardiomyopathy | 2018-09-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001078486 | SCV001009150 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415466 | SCV002677582 | likely benign | Cardiovascular phenotype | 2018-07-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000777961 | SCV004239781 | likely benign | Cardiomyopathy | 2023-01-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541103 | SCV004758810 | likely benign | TNNT2-related disorder | 2020-04-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000777961 | SCV004815041 | likely benign | Cardiomyopathy | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000036620 | SCV001920835 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000724379 | SCV001957036 | likely benign | not provided | no assertion criteria provided | clinical testing |